Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRISABOROLE vs CRIZANLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CRISABOROLE vs CRIZANLIZUMAB: Safety Overview

Metric CRISABOROLE CRIZANLIZUMAB
Total FAERS Reports 7,784 126
Deaths Reported 22 16
Death Rate 0.3% 12.7%
Hospitalizations 53 65
Average Patient Age 39.7 yrs 28.3 yrs
% Female Patients 65.9% 53.5%
FDA Approval Date Dec 14, 2016 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Novartis Pharmaceuticals Corporation
Route TOPICAL INTRAVENOUS
Marketing Status Prescription N/A